Interim data from a phase 3 trial of a COVID-19 vaccine developed in China (CoronaVac) suggests that two doses offer 83.5% protection against symptomatic COVID-19.
Jul 9, 2021
0
4
More than 74 million Americans have thus far been fully vaccinated against COVID-19 – that's a fraction of the U.S. population. Vaccines are perhaps the best hope, along with following safety protocols, for ending the pandemic. ...
Apr 14, 2021
0
3
US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its COVID-19 vaccine among very young children were accurate, ahead of a decision next week on whether to authorize two ...
Jun 10, 2022
0
8
COVID-19 vaccine passports could be created, but significant challenges need to be overcome first, according to a report today from a panel led by Oxford Professors Melinda Mills and Chris Dye, which outlines a dozen issues ...
Feb 19, 2021
0
2
The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, ...
Feb 13, 2017
0
21
An advisory panel to the U.S. Food and Drug Administration voted unanimously on Thursday to recommend that COVID-19 booster shots be updated for the fall to protect solely against one of the three XBB variants that have taken ...
Jun 16, 2023
0
2
The Association for Molecular Pathology (AMP) opposed the National Institutes of Health (NIH) proposal to exclusively license the subject matter of a cancer-related proteonomics patent application filed by the Agency. AMP's ...
Nov 22, 2011
1
0
A new editorial paper titled "Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma" has been published in Oncotarget.
Jul 19, 2023
0
1
People with autoimmune or auto-inflammatory rheumatic diseases have an increased risk of infections. This can be due to the underlying disease itself, or may be caused by treatment with immunomodulating or immunosuppressive ...
Oct 28, 2022
0
15
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, modified an experimental malaria vaccine and showed that it completely protected four of eight ...
May 22, 2017
0
35
